Membrane Technology in the Pharmaceutical Companies, Investment and Capital Allocation

Latest Updates of Key Players in the Membrane Technology in Pharmaceutical Market with Market Growth

Merck KGaA

Headquarter: Germany
Latest updates: Merck presents advanced pharma and electronic materials production to Robert Habeck.

Sartorius AG

Headquarter: Germany
Latest updates: Sartorius membranes are available in a wide variety of pore sizes, structures, and surface characteristics to serve nearly unlimited selectivity of separation.

Danaher Corporation

Headquarter: United States
Latest updates: In May 2025, Danaher entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered.

Thermo Fisher Scientific Inc.

Headquarter: United States
Latest updates: In December 2025, Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry.

3M Company

Headquarter: United States
Latest updates: 3M's immersion in membrane technology for the healthcare sector is defined by the major divestiture of its separation and purification business.

Repligen Corporation

Headquarter: United States
Latest updates: Repligen acquired Metenova, an important Swedish innovator in magnetic combination technology for biopharmaceutical production.

Value Chain Analysis

R&D:

• Major R&D processes includes in membrane design, fabrication, characterization, and application development (scale-up).
• Key Players:  Thermo Fisher Scientific and Parker Hannifin

Manufacturing Processes:

• Major manufacturing processes include microfiltration for sterilization, ultrafiltration for protein purification, nanofiltration for virus elimination, and reverse osmosis for water purification.
• Key Players:  3M and Danaher

Patient Services:

• Membrane technology in the pharmaceutical industry serves as a significant, high-efficiency, and ecologically friendly device for industrial safety, high-purity, and efficient medications.
• Key Players:  Merck and Sartorius

Market Growth

The global membrane technology in the pharmaceutical market size was estimated at USD 2.51 billion in 2025 and is predicted to increase from USD 2.66 billion in 2026 to approximately USD 4.43 billion by 2035, expanding at a CAGR of 5.85% from 2026 to 2035.

Recent Developments in the Membrane Technology in Pharmaceutical Market

• In January 2026, Toray Industries, Inc., announced that it had started selling a high-efficiency separation membrane module for biopharmaceutical purification processes. This model delivers more than four times the filtration performance of its counterparts with a module that is just one-fifth their volume, saving space and reducing buffer solution usage.
• In July 2025, Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.
• In September 2025, DuPont signed an agreement to acquire Sinochem (Ningbo) RO Memtech Co., Ltd. to expand its reverse osmosis (RO) manufacturing footprint into China and the Asia Pacific region.

Get complete dashboard access under one roof for seamless insights and smarter decisions: Access the Dashboard